Hunan Jiudian Pharmaceutical Co (SZSE:300705) Long-Term Debt : ¥345 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Hunan Jiudian Pharmaceutical Co Long-Term Debt?

Hunan Jiudian Pharmaceutical Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥345 Mil.

Hunan Jiudian Pharmaceutical Co's quarterly Long-Term Debt declined from Sep. 2023 (¥554 Mil) to Dec. 2023 (¥332 Mil) but then increased from Dec. 2023 (¥332 Mil) to Mar. 2024 (¥345 Mil).

Hunan Jiudian Pharmaceutical Co's annual Long-Term Debt increased from Dec. 2021 (¥224 Mil) to Dec. 2022 (¥231 Mil) and increased from Dec. 2022 (¥231 Mil) to Dec. 2023 (¥332 Mil).

Hunan Jiudian Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Hunan Jiudian Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Jiudian Pharmaceutical Co Long-Term Debt Chart

Hunan Jiudian Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

68.72

70.50

224.28

231.49

332.48

Hunan Jiudian Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															278.02	275.27	554.22	332.48	344.51

Hunan Jiudian Pharmaceutical Co (SZSE:300705) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Hunan Jiudian Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Hunan Jiudian Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Jiudian Pharmaceutical Co (SZSE:300705) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jiudian Pharmaceutical Co Ltd (SZSE:300705) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

No.1 Health Avenue, Hunan Liuyang Bio Pharmaceutical Park, Hunan, Changsha, CHN, 410329

Website

http://www.jiudianph.com

Hunan Jiudian Pharmaceutical Co Ltd is a China-based pharmaceutical company specializing in research and development, manufacturing of pharmaceutical products, solid and liquid oral preparations and herbal extract products. It manufactures dirithromycin, levodropropizine and levocetirizine hydrochloride in China. The group's products include active pharmaceutical ingredients, herbal extracts, intermediaries, excipients and finished products.

Executives

Zheng Xia Hui	Directors, executives
Duan Li Xin	Director
Zhu Zhi Yun	Director
Xiong Ying	Executives
Zhu Zhi Hong	Director
Li Min	Secretary Dong
Fan Peng Yun	Executives

Hunan Jiudian Pharmaceutical Co (SZSE:300705) Headlines

No Headlines